Dear all
I'd appreciate some further info on a couple of things:
Will data be made available regarding presence of abnormal findings on structural imaging, or does this need to be ascertained by researchers from the raw scans?
The documentation states that "A future pipeline version will include automatic segmentation of white-matter hyperintensities (lesions), primarily utilising the T2_FLAIR data" - is there any indication of a timeline for this?
Many thanks
Breda Cullen
Institute of Health and Wellbeing
University of Glasgow
|